Simple breath test may predict COPD Flare-Ups

NCT ID NCT07045948

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study follows 100 adults with COPD for one year to see how airway inflammation changes over time. Researchers use a simple breath test (FeNO) and a blood sample to measure inflammation markers. Participants visit the clinic three times—at the start, 6 months, and 12 months—to track lung function and symptoms. The goal is to understand why some people have flare-ups while others stay stable.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors better predict COPD flare-ups by monitoring simple breath and blood markers.

What could go wrong

This is an observational study with no treatment being tested, so it won't directly improve health. Results may not apply to all COPD patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease COPD, severe early onset

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Universitair Ziekenhuis Brussel

    RECRUITING

    Jette, 1090, Belgium

    Contact Phone: •••-•••-•••• Email: •••••@•••••